Anne‐Laurène Colin

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Centre Hospitalier Universitaire de Toulouse(Current)

Centre Hospitalier Universitaire Henri-Mondor

Hôpital Saint-Louis

Centre Hospitalier Universitaire de Caen Normandie

Institut universitaire du cancer de Toulouse Oncopole

Anne‐Laurène Colin is an author at Centre Hospitalier Universitaire de Toulouse specializing in refractory multiple myeloma, multiple myeloma treatment, and multiple myeloma.

Publications per year

2018–2023

Publications

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Murielle Roussel, Valérie Lauwers‐Cancès, Margaret Macro et al. · Blood · 2022 · 25 citations · Full text

Medicine, Hematology, Oncology +16

Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma

Laura Rosiñol Dachs, Benjamin Hébraud, Albert Oriol et al. · Blood · 2018 · 22 citations

Medicine, Hematology, Oncology +16

Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma

Laura Rosiñol, Benjamin Hébraud, Albert Oriol et al. · Frontiers in Oncology · 2023 · 16 citations · Full text

Medicine, Hematology, Oncology +16

Detection of drug safety signals from clinical trials data: Role of SUSARs

Christelle Pérez, Pascale Olivier, Barbara Lortal et al. · Pharmacological Research · 2018 · 11 citations

Pharmacy, Pharmacology, Drug Approval Processes +12

1–4 of 4